Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients

Clinical Transplantation

Volumn 19, Issue 3, 2005, Pages 367-371

  De Chiara, Benedetta ^a   Bigi, Riccardo ^a   Campolo, Jonica ^a   Parolini, Marina ^a   Turazza, Fabio ^a,b   Masciocco, Gabriella ^a   Frigerio, Maria ^a   Fiorentini, Cesare ^c   Parodi, Oberdan ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c University Hospital S Paolo   (Italy)

Author keywords

Antioxidants; Cardiac allograft vasculopathy; Free radicals; Glutathione; Heart transplantation

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; CYCLOSPORIN; CYSTEINE; CYSTEINYLGLYCINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLUTATHIONE; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; PREDNISONE; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; BLOOD LEVEL; BLOOD SAMPLING; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTIVARIATE ANALYSIS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RECIPIENT; SCAVENGING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; VITAMIN BLOOD LEVEL;

BIOLOGICAL MARKERS; GLUTATHIONE; HEART TRANSPLANTATION; HUMANS; MALE; OXIDATION-REDUCTION; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 19044381132     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00352.x     Document Type: Article

References (23)

1. Costanzo MR, Naftel DC, Pritzker MR et al. Heart transplant coronary artery disease detected by coronary angiography: a multinstitutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant 1998: 17: 744.
2. Yeung AC, Davis SF, Hauptman PJ et al. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant 1995: 14: S215.
3. Vassalli G, Gallino A, Weis M et al. Working Group Microcirculation of the European Society of Cardiology. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 2003: 24: 1180.
4. Slakey D, Roza A, Pieper G, Johnson C, Adams M. Ascorbic acid and alpha-tocopherol prolong rat cardiac allograft survival. Transplant Proc 1993: 25: 610.
5. Fang JC, Kinlay S, Beltrame J et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 2002: 359: 1108.
6. Caldera A, Dec GW. Hyperhomocysteinemia and transplant coronary artery disease. Transplantation 2002: 74: 1359.
7. Gupta A, Moustapha A, Jacobsen DW et al. High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients. Transplantation 1998: 65: 544.
8. Ambrosi P, Barlatier A, Habib G et al. Hyperhomocysteinaemia in heart transplant recipients. Eur Heart J 1994: 15: 1191.
9. Billingham ME, Cary NR, Hammond ME et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990: 9: 587.
10. Accinni R, Campolo J, Bartesaghi S et al. High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards. J Chromatogr A 1998: 828: 397.
11. Hultqvist M, Hegbrant J, Nilsson-Thorell C et al. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin Nephrol 1997: 47: 37.
12. Cook RC, Tupper JK, Parker S et al. Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation. J Heart Lung Transplant 1999: 18: 420.
13. Arnadottir M, Hultberg B, Vladov V, Nilsson-Ehle P, Thysell H. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation 1996: 61: 509.
14. Ambrosi P, Garcon D, Riberi A et al. Association of mild hyperhomocysteinemia with cardiac graft vascular disease. Atherosclerosis 1998: 138: 347.
15. Miner SE, Cole DE, Evrovski J, Verma A, Daly PA, Ross HJ. Hyperhomocysteinemia and transplant coronary artery disease in cardiac transplant recipients. Clin Transplant 2001: 15: 258.
16. Di Giuseppe D, Di Simplicio P, Capecchi PL, Lazzerini PE, Pasini FL. Alteration in the redox state of plasma in heart-transplant patients with moderate hyperhomocysteinemia. J Lab Clin Med 2003: 142: 21.
17. Holvoet P, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 2000: 20: 698.
18. Chancerelle Y, de Lorgeril M, Viret R. Increased lipid peroxidation in cyclosporin-treated heart transplant recipients. Am J Cardiol 1991: 68: 813.
19. Upchurch GR Jr, Welch GN, Fabian AJ et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997: 272: 17012.
20. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinyl-glycine, homocysteine, and glutathione in human plasma. Anal Biochem 1992: 200: 218.
21. Calo L, Semplicini A, Davis PA et al. Cyclosporin-induced endothelial dysfunction and hypertension: are nitric oxide system abnormality and oxidative stress involved? Transpl Int 2000: 13: S413.
22. Arnadottir M, Hultberg B, Wahlberg J, Fellstrom B, Dimeny E. Serum total homocysteine concentration before and after renal transplantation. Kidney Int 1998: 54: 1380.
23. Jimenez R, Galan AI, Gonzalez de Buitrago JM, Palomero J, Munoz ME. Glutathione metabolism in cyclosporine A-treated rats: dose- and time-related changes in liver and kidney. Clin Exp Pharmacol Physiol 2000: 27: 991.